<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A total of 1,394 patients with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were treated at the Princess Margaret Hospital between January 1, 1967 and December 31, 1978 </plain></SENT>
<SENT sid="1" pm="."><plain>Overall actuarial survival of 525 patients with nodular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> was 40% at 12 years; survival of patients with localized (Stage I &amp; III) nodular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> treated with radical radiation therapy was 58% </plain></SENT>
<SENT sid="2" pm="."><plain>Significant prognostic factors defined by multivariate analysis included patient's age, stage, histology, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> bulk, and presence of B symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>By combining prognostic factors we have identified distinct prognostic groups within the overall population </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with Stage I &amp; II disease, small or medium bulk, less than 70 years of age achieved 92% 12 year actuarial survival and a 73% relapse-free rate in 12 years of follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>These patients represent groups highly curable with irradiation </plain></SENT>
</text></document>